Fox Run Management, L.L.C. Repligen Corp Transaction History
Fox Run Management, L.L.C.
- $608 Million
- Q1 2025
A detailed history of Fox Run Management, L.L.C. transactions in Repligen Corp stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 18,848 shares of RGEN stock, worth $2.39 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
18,848
Previous 4,635
306.65%
Holding current value
$2.39 Million
Previous $667,000
259.52%
% of portfolio
0.39%
Previous 0.13%
Shares
12 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$959 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$959 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$644 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$214 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$212 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.03B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....